ME2 and hepatocellular carcinoma: To further clarify whether R67 is a functionally active site for ME2 methylation, we constructed HCC cell lines in which ME2 expression was knocked down and analyzed the effects of ME2 wild-type (WT) and R67-mutant (R67K) mutations on HCC cells.